Citius Pharmaceuticals
CTXR
CTXR
76 hedge funds and large institutions have $37.5M invested in Citius Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
4% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 23
27% less capital invested
Capital invested by funds: $51.1M → $37.5M (-$13.5M)
Holders
76
Holding in Top 10
–
Calls
$801K
Puts
$319K
Top Buyers
| 1 | +$613K | |
| 2 | +$265K | |
| 3 | +$141K | |
| 4 |
HF
HRT Financial
New York
|
+$139K |
| 5 |
AGM
Alpine Global Management
New York
|
+$129K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$892K | |
| 3 | -$351K | |
| 4 |
Goldman Sachs
New York
|
-$214K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$126K |